References
- Poulsen C O, Jacobsen G K, Nygaard J. The mouse mutant nude as a model for testing anticancer agents. The laboratory animal in drug testing, A Spiegel. Fischer, Stuttgart 1973; 63–72
- Fodstad Ø, Aaas N, Pihl A. Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice. Int J Cancer 1980; 25: 453–8
- Bogden A E, Griffin W, Reich S D, Constanza M E, Cobb W R. Predictive testing with the subrenal capsule assay. Cancer Treat Rev 1984; 11: 113–24
- Aamdal S, Fodstad Ø, Pihl A. Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumours to anticancer agents. Anticancer Res 1985; 5: 329–38
- Volm M, Wayss K, Kaufmann M, Mattern J. Pretherapeutic detection of tumour resistance and the result of tumour chemotherapy. Eur J Cancer 1979; 15: 983–93
- Hill B T. An overview of clonogenic assays for human tumour biopsies. Human tumour drug sensitivity testing in vitro, P P Dendy, B T Hill. Academic Press, London 1983; 91–102
- Shoemaker R H, Wolpert-De Filippes M K, Kern D H, et al. Application of a human tumor colony-forming assay to new drug screening. Cancer Res 1985; 45: 2145–53
- Von Hoff D D, Cowan J, Harris G, Reisdorf G. Human tumor cloning: feasibility and clinical correlations. Cancer Chemother Pharmacol 1985; 6: 265–74
- Tveit K M, Gundersen S, Høie J, Pihl A. Predictive chemosensitivity testing of malignant melanoma. Reliable methodology-ineffective drugs. Br J Cancer 1988; 58: 734–7
- Ottestad L O, Tveit K M, Høifødt H K, et al. Cultivation of human breast carcinomas in soft agar. Experience with 237 fresh tumour specimens. Br J Cancer 1988; 58: 8–12
- Nederman T. Growth of tumour cells as multicellular spheroids and antitumour drug evaluation. Human tumour drug sensitivity testing in vitro, P P Dendy, B T Hill. Academic Press, London 1983; 147–61